CME Group schedules results: Morgan Stanley lifts target for CME Group stock
Published on 10/21/2026 at 10:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTrading activity before results
- CME Group's third-quarter revenue estimate was USD 1.71 billion on October 21, 2026.
- Average daily volume reached 29.4 million contracts in the third quarter, up 16 percent year over year.
- CME Group stock trades at EUR 264.68 at 10:19 a.m. CEST at Lang & Schwarz on October 21, 2026.
CME Group (ISIN US12572Q1058) was scheduled to report third-quarter results before the market open on October 21, 2026, with revenue estimated at USD 1.71 billion. According to Benzinga, Morgan Stanley maintained an Overweight rating and raised its target from USD 330.00 to USD 337.00 on October 9, 2026.
Volume sets the earnings test
The preview centers on whether CME Group can convert heavier activity into comparable revenue growth. Investing.com reported that third-quarter average daily volume reached a record 29.4 million contracts, up 16 percent from the prior year, while September volume reached 31.8 million contracts, up 22 percent.
The comparison with the preceding quarter is demanding. CME Group reported USD 1.71 billion in second-quarter revenue and USD 2.99 in diluted earnings per share, according to Investing.com. The same report said the quarter's earnings per share exceeded a USD 2.95 consensus estimate by USD 0.04.
What does the volume mean for stock?
For CME Group stock, the key issue is operating leverage rather than contract count alone. The company operates futures and options marketplaces across interest rates, equity indexes, foreign exchange, agriculture, energy and metals, giving volume gains several possible revenue channels.
Three dated developments
On July 22, 2026, CME Group reported second-quarter revenue of USD 1.71 billion and diluted earnings per share of USD 2.99, according to Investing.com. On October 2, 2026, the company disclosed third-quarter average daily volume of 29.4 million contracts, up 16 percent year over year. On October 21, 2026, it was scheduled to release third-quarter results before the market open, with consensus revenue of USD 1.71 billion.
Next date on the calendar
The next substantiated company date was October 21, 2026, the scheduled third-quarter earnings release before the market open, as reported by Benzinga.
Price stays tied to the report
CME Group stock was trading at EUR 264.68 at Lang & Schwarz on October 21, 2026, at 10:19 a.m. CEST. The euro quotation gives German investors a live reference while the US listing remains the primary market context.
The further course of trading is shown by the continuously updated real-time quote of CME Group stock.
CME Group stock facts
- Company: CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 21, 2026, 10:19 a.m. CEST): EUR 264.68
- Market capitalization: USD 106.2 billion (as of October 20, 2026)
- 52-week range: USD 218.31-329.16 (as of October 20, 2026)
- Sector / Industry: Financial Services / Financial - Data and Stock Exchanges
- Index membership: S&P 500
Market context: Market report S&P 500.
